WASHINGTON -- Patients with IgG4-related disease appeared to benefit from inebilizumab (Uplizna), currently approved for ...

Don M. Benson, MD, PhD, has cared for patients at James Cancer Hospital in Ohio for 22 years, where he and his team see approximately 10,000 patient visits each year.

Put up against placebo in the phase 3 EMBARK trial, delandistrogene moxeparvovec (Elevidys) did not significantly improve ...

A delay in the FDA decision for NT-501 could leave those with macular telangiectasia (MacTel) without any form of treatment ...

Findings of a recent study indicate that NUP98 rearrangements can significantly impact outcomes in patients with acute myeloid leukemia (AML).

Do you have a favorite musical? How many show-tune lyrics do you know? Do you love Broadway? By Shannon Doyne How do you feel about automated vehicles? What effects do you think they will have ...

Jason Wiese writes feature stories for CinemaBlend. His occupation results from years dreaming of a filmmaking career, settling on a "professional film fan" career, studying journalism at ...

The high fire danger continues Friday, and we’ve got a warm weekend ahead. But there is a sign of some rain in the 10-day forecast.

Explore courses shaped by industry, state-of-the-art facilities and a community that will challenge, excite and support you. Discover a community that will inspire and support you and give you the ...